Bradykinin and its role in osteoarthritis
Osteoarthritis (OA), the most common joint disorder, is a disease involving all the articular structures. It presents both degenerative and inflammatory aspects. Recently, the important role of Bradykinin (BK), a phlogistic mediator, has been proposed in the pathophysiology of OA. In our review, we...
Main Authors: | L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2013-07-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/670 |
Similar Items
-
Can’t Intubate, Can’t Oxygenate: A Rare Case of a Difficult Airway due to Nonhereditary Angioedema
by: Điđi Delalić, et al.
Published: (2022-01-01) -
Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain
by: Mar Guilarte, et al.
Published: (2021-12-01) -
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist
by: Anne Lesage, et al.
Published: (2020-06-01) -
Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
by: Bahareh Rasaeifar, et al.
Published: (2020-09-01) -
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01)